share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
美股SEC公告 ·  11/19 08:10

Moomoo AI 已提取核心信息

Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a series of stock transactions between November 14, 2024, and November 15, 2024. Burnett engaged in both the acquisition and disposal of common stock shares. On November 14, Burnett acquired 18,377 shares at no cost, an action described as the exercise or conversion of derivative security. On the same day, Burnett sold 50,749 shares at a price of $10.2945 per share, followed by the sale of 18,377 shares at the same price, both transactions classified as open market or private sales. The following day, Burnett acquired 100 shares, again at no cost, and sold the same number of shares at $10.03 each. After these transactions, Burnett held a total of 128,669 shares of Arcutis Biotherapeutics. The total value of the disposed shares amounted to approximately $712,620.61.
Patrick Burnett,与arcutis biotherapeutics,Inc. [ARQT]有关,在2024年11月14日至2024年11月15日期间完成了一系列股票交易。Burnett参与了普通股的收购和处理。11月14日,Burnett免费取得18,377股股票,这个行为被描述为衍生类证券的行权或转换。同一天,Burnett以每股10.2945美元的价格出售了50,749股,在随后以同样价格出售了18,377股股票,这两笔交易均被归类为公开市场或私人销售。次日,Burnett再次免费取得100股,并以每股10.03美元的价格出售了同样数量的股票。在这些交易之后,Burnett持有arcutis biotherapeutics的总计128,669股股票。已处理股票的总价值约为$712,620.61。
Patrick Burnett,与arcutis biotherapeutics,Inc. [ARQT]有关,在2024年11月14日至2024年11月15日期间完成了一系列股票交易。Burnett参与了普通股的收购和处理。11月14日,Burnett免费取得18,377股股票,这个行为被描述为衍生类证券的行权或转换。同一天,Burnett以每股10.2945美元的价格出售了50,749股,在随后以同样价格出售了18,377股股票,这两笔交易均被归类为公开市场或私人销售。次日,Burnett再次免费取得100股,并以每股10.03美元的价格出售了同样数量的股票。在这些交易之后,Burnett持有arcutis biotherapeutics的总计128,669股股票。已处理股票的总价值约为$712,620.61。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息